Spiriva and Lubiprostone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Spiriva (tiotropium bromide monohydrate) and Lubiprostone (lubiprostone). Common drug interactions include dizziness among females and neutropenia among males.

The phase IV clinical study analyzes what interactions people have when they take Spiriva and Lubiprostone. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Spiriva?

Spiriva has active ingredients of tiotropium bromide monohydrate. It is often used in chronic obstructive pulmonary disease. eHealthMe is studying from 156,666 Spiriva users. Check the latest studies of Spiriva.

What is Lubiprostone?

Lubiprostone has active ingredients of lubiprostone. eHealthMe is studying from 957 Lubiprostone users. Check the latest studies of Lubiprostone.



On Jul, 05, 2026

11 people who take Spiriva and Lubiprostone together, and have interactions are studied.

Spiriva and Lubiprostone drug interactions.

What are the common drug interactions of Spiriva and Lubiprostone, by gender? *:

female:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Weight decreased
  4. Abdominal discomfort
  5. Abdominal pain
  6. Anaemia (lack of blood)
  7. Aortic aneurysm (enlargement of an aortic artery caused by a weakening of the artery wall)
  8. Arthralgia (joint pain)
  9. Blood creatine increased
  10. Chest discomfort

male:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  3. Constipation
  4. Diarrhoea
  5. Dizziness
  6. Drug effect decreased
  7. Dyspnoea (difficult or laboured respiration)
  8. Fatigue (feeling of tiredness)
  9. Head discomfort
  10. Lung disorder (lung disease)

What are the common drug interactions of Spiriva and Lubiprostone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Chronic kidney disease

50-59:

  1. Neutropenia (an abnormally low number of neutrophils)
  2. Non-hodgkin's lymphoma (malignant (cancer) cells form in the lymph system)
  3. Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
  4. Neoplasm malignant (cancer tumour)

60+:

  1. Dizziness
  2. Nausea (feeling of having an urge to vomit)
  3. Arthralgia (joint pain)
  4. Asthenia (weakness)
  5. Blood creatine increased
  6. Chest discomfort
  7. Constipation
  8. Contusion (a type of hematoma of tissue in which capillaries)
  9. Cough
  10. Decreased appetite

What are the existing conditions these people have? *

  1. Constipation: 4 people, 36.36%
  2. Emphysema (chronic respiratory disease - over inflation of the air sacs (alveoli) in the lungs): 3 people, 27.27%
  3. Fever: 3 people, 27.27%
  4. Pain: 3 people, 27.27%
  5. High Blood Pressure: 3 people, 27.27%
  6. Stress And Anxiety: 3 people, 27.27%
  7. High Blood Cholesterol: 3 people, 27.27%
  8. Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur): 3 people, 27.27%
  9. Gastrointestinal Disorder (functional problems of gastrointestinal tract): 2 people, 18.18%
  10. Fibromyalgia (a long-term condition which causes pain all over the body): 2 people, 18.18%

* Approximation only. Some reports may have incomplete information.

Do you take Spiriva and Lubiprostone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Spiriva and Lubiprostone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Spiriva:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lubiprostone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Spiriva and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lubiprostone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on tiotropium bromide monohydrate and lubiprostone (the active ingredients of Spiriva and Lubiprostone, respectively), and Spiriva and Lubiprostone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: